239 related articles for article (PubMed ID: 9111619)
1. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.
Moreno JG; O'Hara SM; Long JP; Veltri RW; Ning X; Alexander AA; Gomella LG
Urology; 1997 Apr; 49(4):515-20. PubMed ID: 9111619
[TBL] [Abstract][Full Text] [Related]
2. The detection of prostate cells by the reverse transcription-polymerase chain reaction in the circulation of patients undergoing transurethral resection of the prostate.
Heung YM; Walsh K; Sriprasad S; Mulvin D; Sherwood RA
BJU Int; 2000 Jan; 85(1):65-9. PubMed ID: 10619948
[TBL] [Abstract][Full Text] [Related]
3. Detection and clearance of prostate cells subsequent to ultrasound-guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay.
Price DK; Clontz DR; Woodard WL; Kaufman JS; Daniels JM; Stolzenberg SJ; Teigland CM
Urology; 1998 Aug; 52(2):261-6; discussion 266-7. PubMed ID: 9697792
[TBL] [Abstract][Full Text] [Related]
4. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
Feneley MR; Webb JA; McLean A; Kirby RS
Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
[TBL] [Abstract][Full Text] [Related]
5. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
Koutsilieris M; Lembessis P; Luu-The V; Sourla A
Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of benign prostatic hyperplasia from prostate cancer using prostate specific antigen dynamic profile after transrectal prostate biopsy.
Lin TP; Huang WJ; Chen KK
J Urol; 2004 Jun; 171(6 Pt 1):2226-9. PubMed ID: 15126790
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
[TBL] [Abstract][Full Text] [Related]
8. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
9. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
10. Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy.
Hara N; Kasahara T; Kawasaki T; Bilim V; Tomita Y; Obara K; Takahashi K
Br J Cancer; 2001 Aug; 85(4):557-62. PubMed ID: 11506496
[TBL] [Abstract][Full Text] [Related]
11. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
13. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies.
Rovner ES; Schanne FJ; Malkowicz SB; Wein AJ
J Urol; 1997 Jul; 158(1):138-41; discussion 141-2. PubMed ID: 9186340
[TBL] [Abstract][Full Text] [Related]
14. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].
Popov SV; Guseinov RG; Skryabin ON; Orlov IN; Martov AG
Urologiia; 2018 Jul; (3):92-97. PubMed ID: 30035426
[TBL] [Abstract][Full Text] [Related]
16. Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction.
Lintula S; Vesalainen S; Rannikko A; Zhang WM; Finne P; Stenman J; Stenman UH
Scand J Clin Lab Invest; 2004 Apr; 64(2):93-100. PubMed ID: 15115245
[TBL] [Abstract][Full Text] [Related]
17. Could the sextant prostate biopsy be replaced by transurethral resection?
Startsev VY; Pouline I; Gorelov S; Merkulova R
Arch Ital Urol Androl; 2005 Dec; 77(4):194-8. PubMed ID: 16444931
[TBL] [Abstract][Full Text] [Related]
18. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
Gao CL; Maheshwari S; Dean RC; Tatum L; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
Urology; 1999 Apr; 53(4):714-21. PubMed ID: 10197846
[TBL] [Abstract][Full Text] [Related]
19. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
[TBL] [Abstract][Full Text] [Related]
20. Can prostate-specific antigen reverse transcriptase-polymerase chain reaction be used as a prospective test to diagnose prostate cancer?
Goldman HB; Israeli RS; Lu Y; Lerner JL; Hollabaugh RS; Steiner MS
World J Urol; 1997; 15(4):257-61. PubMed ID: 9280055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
